Franz Obermayr
Chief Executive Officer bij Panoptes Pharma GmbH
Profiel
Franz Obermayr is the founder and Chief Executive Officer of Panoptes Pharma GmbH since 2013.
He was also the Head of Clinical Development at Nabriva Therapeutics Plc from 2009 to 2013.
In addition, he served as Director of Drug Discovery at GPC Biotech, Inc. Dr. Obermayr was also the Executive Vice President of Clinical Development at Kiora Pharmaceuticals, Inc. in 2021.
Actieve functies van Franz Obermayr
Bedrijven | Functie | Begin |
---|---|---|
Panoptes Pharma GmbH
Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Chief Executive Officer | 01-07-2013 |
Eerdere bekende functies van Franz Obermayr
Bedrijven | Functie | Einde |
---|---|---|
KIORA PHARMACEUTICALS, INC. | Chief Executive Officer | 26-07-2021 |
NABRIVA THERAPEUTICS PLC | Corporate Officer/Principal | 01-01-2013 |
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
KIORA PHARMACEUTICALS, INC. | Health Technology |
NABRIVA THERAPEUTICS PLC | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
GPC Biotech, Inc.
GPC Biotech, Inc. Drugstore ChainsRetail Trade GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA. | Retail Trade |
Panoptes Pharma GmbH
Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Health Technology |